Frontier Technologies

Frontier Technologies


Nancy J Kelley + Associates works to evaluate the state and value of transformative discoveries to create opportunities for investment and growth.

Nancy J Kelley + Associates works to evaluate the state and value of transformative discoveries to create opportunities for investment and growth.
Our services include:
  • Competitive Landscape Analysis
  • Technology + Market Fit Assessment
  • Technical Due Diligence
  • Strategic Planning
  • Commercialization Strategy
  • Patent/Licensing Evaluation
  • Intellectual Property Strategy
  • Partnership Strategy
Understanding the Practical Implications of Genetic Technology

“The GP-write grand challenge is more ambitious and more focused on understanding the practical applications than the original Human Genome Project. Exponential improvements in genome engineering technologies and functional testing provide an opportunity to deepen the understanding of our genetic blueprint and use this knowledge to address many of the global problems facing humanity.”


George Church, PhD; Professor of Genetics, Harvard Medical School
Core Faculty Member, Wyss Institute for Biologically Inspired Engineering

Bridging the Gap between Science & Business

“Nancy J Kelley + Associates brought a collaborative approach and strategic perspective that bridged the gap between science and business to launch a successful personalized genomic medicine company for Roswell Park Cancer Institute. Their ability to coordinate a series of complex partnerships across a broad array of scientific and technological disciplines was invaluable to the success of the venture.”


Donald Trump, MD, FACP, CEO and Executive Director,
Inova Cancer Research Institute, Inova Health System
CEO, Emeritus and Professor Oncology
Roswell Park Cancer Institute

NJK+A Frontier Technologies • Related Videos


Building a Human Genome from scratch
Genome Foundry@ISG

Robert B Darnell & Nancy J Kelley
Extended Interview / New York Genome Center

cell and gene therapy report

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. This report was done by CEO Council for Growth in Philadelphia. It helps to confirm the broad life science real estate trends that were highlighted at the Philly Builds Bio Inaugural Symposium for Life Science Innovation and Development, held on September 13, 2022.


View Report (PDF)
Nancy Kelley and Stephen Grupp

Nancy J Kelley with Dr. Stephen Grupp, MD PhD, a pioneer in Cell and Gene Therapy, at the Philly Builds BIO+ Symposium

  • View a moving documentary about the revolutionary technologies being developed by Dr. Grupp and others in Philadelphia entitled "Of Medicine and Miracles" recently introduced at the Tribeca Film Festival

View Documentary

"All significant breakthroughs were breaks with old ways of thinking. We must replace an old paradigm with a new one."

Thomas S Kuhn, American Philosopher of Science


Image

"All significant breakthroughs were breaks with old ways of thinking. We must replace an old paradigm with a new one."

Thomas S Kuhn, American Philosopher of Science


LET'S GET STARTED!